Literature DB >> 7743621

Sudden death, impaired glucose tolerance, and diabetes in Japanese American men.

J D Curb1, B L Rodriguez, C M Burchfiel, R D Abbott, D Chiu, K Yano.   

Abstract

BACKGROUND: Diabetes and glucose intolerance have been shown to increase the risk of cardiovascular mortality in a number of different populations. Most studies have been based on short follow-up periods, and few have had sufficient numbers to allow researchers to look at sudden death as an outcome. METHODS AND
RESULTS: The relation of sudden death, defined as unexpected death occurring within either 1 or 24 hours of first symptoms, to glucose intolerance measured by a nonfasting 1-hour postload measurement made in 1965 or history of diabetes was examined by use of 23 years of follow-up on the 8006 participants enrolled in the Honolulu Heart Program. After adjustment for baseline body mass index, hypertension, cholesterol, triglycerides, smoking, alcohol consumption, and left ventricular hypertrophy or strain, the relative risks for sudden death within 24 hours in individuals with high-normal (151 to 224 mg/dL), asymptomatic high glucose values (> or = 225 mg/dL), and diabetes compared with those with lower glucose values (< 151 mg/dL) were 1.59, 2.22, and 2.76, respectively. All these relative risks were statistically significant (P < or = .05). Trends for sudden death in 1 hour were similar. Among men with sudden death < 1 hour after onset of symptoms, the strength of the association between diabetes and sudden death was stronger among those classified as having died of unknown causes who thus were more likely to have died of an arrhythmia than among those classified as having died of coronary heart disease.
CONCLUSIONS: The relations seen in these analyses indicate that individuals with glucose intolerance or diagnosed diabetes are at increased risk for sudden death.

Entities:  

Mesh:

Year:  1995        PMID: 7743621     DOI: 10.1161/01.cir.91.10.2591

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  32 in total

Review 1.  Impaired fasting glucose as a treatment target in diabetes management.

Authors:  Rene A Oliveros; Adrienne S Zion; Yelena Rosenberg; Carrie Lynn Selvaraj; Robert Chilton
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

2.  Ryanodine receptor phosphorylation by CaMKII promotes spontaneous Ca(2+) release events in a rodent model of early stage diabetes: The arrhythmogenic substrate.

Authors:  Leandro Sommese; Carlos A Valverde; Paula Blanco; María Cecilia Castro; Omar Velez Rueda; Marcia Kaetzel; John Dedman; Mark E Anderson; Alicia Mattiazzi; Julieta Palomeque
Journal:  Int J Cardiol       Date:  2015-09-25       Impact factor: 4.164

3.  T-wave alternans and heart rate variability: a comparison in patients with myocardial infarction with or without diabetes mellitus.

Authors:  LiNa Ren; XinHui Fang; Yongquan Wang; Guoxian Qi
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-07       Impact factor: 1.468

Review 4.  Drugs for cardiovascular risk reduction in the diabetic patient.

Authors:  D S Bell
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

5.  Diabetes increases mortality after myocardial infarction by oxidizing CaMKII.

Authors:  Min Luo; Xiaoqun Guan; Elizabeth D Luczak; Di Lang; William Kutschke; Zhan Gao; Jinying Yang; Patric Glynn; Samuel Sossalla; Paari D Swaminathan; Robert M Weiss; Baoli Yang; Adam G Rokita; Lars S Maier; Igor R Efimov; Thomas J Hund; Mark E Anderson
Journal:  J Clin Invest       Date:  2013-02-15       Impact factor: 14.808

6.  [ESC/EASD joint guidelines on diabetes and cardiovascular diseases].

Authors:  Wolfgang Motz; Rolf Dörr
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

7.  Use of the dietary supplement 5-aminiolevulinic acid (5-ALA) and its relationship with glucose levels and hemoglobin A1C among individuals with prediabetes.

Authors:  Beatriz L Rodriguez; J David Curb; James Davis; Terry Shintani; Michael H Perez; Noelani Apau-Ludlum; Crystal Johnson; Rosanne C Harrigan
Journal:  Clin Transl Sci       Date:  2012-06-01       Impact factor: 4.689

Review 8.  Sudden cardiac death in patients with diabetes.

Authors:  Fadi A El-Atat; Samy I McFarlane; James R Sowers; J Thomas Bigger
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

9.  Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP.

Authors:  Ho-Jin Park; Serban P Georgescu; Chuang Du; Christopher Madias; Mark J Aronovitz; C Michael Welzig; Bo Wang; Ulrike Begley; Yali Zhang; Robert O Blaustein; Richard D Patten; Richard H Karas; Herbert H Van Tol; Timothy F Osborne; Hitoshi Shimano; Ronglih Liao; Mark S Link; Jonas B Galper
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 10.  Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.

Authors:  Rehan Qayyum; Shari Bolen; Nisa Maruthur; Leonard Feldman; Lisa M Wilson; Spyridon S Marinopoulos; Padmini Ranasinghe; Muhammed Amer; Eric B Bass
Journal:  Ann Intern Med       Date:  2008-09-15       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.